Femur AP Proximal – AP Distal Femur

Posted on



Advertisements

23 thoughts on “Femur AP Proximal – AP Distal Femur

    electricien 78 yvelines said:
    July 31, 2014 at 12:10 pm

    Wow, great article post.Thanks Again. Great.
    electricien 78 yvelines

    serrurier 95 val-d'oise said:
    July 31, 2014 at 9:42 am

    I really like and appreciate your article post.Thanks Again. Awesome.
    serrurier 95 val-d’oise

    best tablets on the market said:
    July 30, 2014 at 10:35 pm

    Great, thanks for sharing this article.Much thanks again. Great.
    tablet deals

    best tablets 2013 said:
    July 30, 2014 at 9:02 am

    Im obliged for the blog post. Will read on…
    best tablets on the market

    Salads Delivery said:
    July 30, 2014 at 8:53 am

    Wow, great blog article.Thanks Again. Will read on…
    Ice Cream Delivery

    business loans said:
    July 28, 2014 at 12:10 pm

    I really like and appreciate your post.Much thanks again. Will read on…
    bridge loans

    serrurier 92 hauts-de-seine said:
    July 28, 2014 at 8:12 am

    Great, thanks for sharing this blog post.Really looking forward to read more. Will read on…
    serrurier 92 hauts-de-seine

    adams county bail bondsman said:
    July 26, 2014 at 5:31 am

    I loved your blog article. Want more.
    arapahoe county bail bonds

    electrician columbia sc said:
    July 25, 2014 at 5:46 am

    Wow, great blog post.Really looking forward to read more. Great.
    electricians in columbia sc

    caterers columbia sc said:
    July 24, 2014 at 5:35 am

    Thanks for sharing, this is a fantastic blog article.Really looking forward to read more. Awesome.
    catering services in columbia sc

    Surprise Plumber said:
    July 23, 2014 at 8:51 am

    Thanks-a-mundo for the blog article.Really looking forward to read more.
    Surprise Plumber

    Avondale Electrician said:
    July 23, 2014 at 4:30 am

    Appreciate you sharing, great blog post. Much obliged.
    Avondale Electrician

    weights said:
    July 21, 2014 at 2:36 pm

    Thanks for the blog article.Really looking forward to read more. Will read on…
    sporting goods

    newsletter marketing for home care said:
    July 21, 2014 at 7:53 am

    Im obliged for the blog.Much thanks again. Want more.
    sales tools for home care agencies

    Wohnung kaufen in Alanya said:
    July 18, 2014 at 7:37 am

    Major thankies for the blog post.Really thank you! Much obliged.
    Immobilienkauf in Alanya

    localstake said:
    July 16, 2014 at 6:02 am

    Very good blog article. Cool.
    localstake

    Femme de mГ©nage Г  montrГ©al said:
    July 15, 2014 at 6:18 am

    Say, you got a nice article post.Really looking forward to read more. Cool.
    Entretien mГ©nager Г  montrГ©al

    improving search engine optimization said:
    July 14, 2014 at 2:57 am

    Enjoyed every bit of your post. Awesome.
    indianapolis search engine optimization

    hattiesburg house plans said:
    July 12, 2014 at 11:59 am

    Thanks again for the blog article.Really looking forward to read more. Fantastic.
    residential designs

    ant moat for hummingbird feeders said:
    July 12, 2014 at 6:57 am

    I value the blog post.Really looking forward to read more. Will read on…
    ant trap hummingbird

    car body repairs in leeds said:
    July 8, 2014 at 11:38 am

    wow, awesome blog.Thanks Again. Cool.
    car body repairs in leeds

    stencils for walls said:
    July 6, 2014 at 10:52 am

    Thanks for sharing, this is a fantastic post.Really looking forward to read more. Will read on…
    wall stencils uk

    New trial model unlocks power of personalized medicine said:
    December 7, 2011 at 10:56 pm

    Oncology clinicians may soon have hundreds of biomarker tests available to them to assist in developing personalized cancer treatments, but some healthcare professionals believe that novel funding approaches for biomarker tests’ studies—a systematic process to move biomarker tests through regulatory agencies and a body of evidence supporting biomarker tests’ benefits—will all be necessary before healthcare system stakeholders accept their use.

    In the December issue of Health Affairs, Scott D. Ramsey, MD, PhD, of the Seattle-based Fred Hutchinson Cancer Research Center and his colleagues proposed a framework for the integrated approach to designing and implementing comparative clinical trials of personalized medicine technologies, including the use of biomarker tests.

    Biomarker tests, also known as genomic tests, are used to measure the unique variables of individuals’ genetic material, proteins and other biological molecules. Those measurements can be used to develop individual assessments of the risk of future disease, the aggressiveness of a disease and possible outcomes of different treatments.

    Ramsey and his colleagues believe that biomarker tests, which are often introduced into clinical practice without sufficient evidence of their benefits, have “tremendous potential for improved outcomes and lower treatment costs,” but propose comparative effectiveness research to “strengthen what is now a haphazard process for developing and marketing cancer biomarker tests.”

    The researchers wrote, “Comparative effectiveness research will be more important at the intersection of personalized medicine and cancer than anywhere else because of the high risks and costs of poor-quality test information about this group of diseases.”

    Ramsey and his colleagues suggested that future clinical trials of biomarker tests:
    •Identify personalized medicine technologies that multiple stakeholder groups, specifically consumers and clinicians, consider high-priority;
    •Be designed to meet the needs of multiple stakeholders;
    •Use clinical trial groups with standing infrastructures in order to conduct studies on a large scale; and
    •Employ funding mechanisms that distribute costs among private and public insurers.
    “For such an approach to be viable,” Ramsey and colleagues wrote, “clinical trials groups, insurers and other interested stakeholders will need to develop standardized methods for assessing clinical validity and clinical utility, particularly in the context of rapidly evolving technology; establish a network of clinical organizations capable of rapidly enrolling patients in these studies; and develop collaborative mechanisms so that payers, clinicians, patients and researchers can work together to design, fund and implement studies.”

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s